GEOVAX LABS INC- WARRANTS
GEOVAX LABS INC- WARRANTS
Acción · US3736781192 · GOVXW (XNAS)
Resumen Indicadores financieros
0,03 USD
-3,70 % -0,001 USD
NASDAQ (XNAS) · Precios actuales y gráficos en MoneyPeak
04.06.2025 16:27

Cotizaciones actuales de GEOVAX LABS INC- WARRANTS

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XNAS: NASDAQ
NASDAQ
GOVXW
USD
04.06.2025 16:27
0,03 USD
0,03 USD
-3,70 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % -0,27 % 83,66 % -66,39 % -73,80 % -10,37 % -96,05 %

Firmenprofil zu GEOVAX LABS INC- WARRANTS Aktie

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

Unternehmensdaten

Name GEOVAX LABS INC- WARRANTS
Firma GeoVax Labs, Inc.
Symbol GOVXW
Website https://www.geovax.com
Heimatbörse XNAS NASDAQ
ISIN US3736781192
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. David Alan Dodd
Marktkapitalisierung 12 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 1900 Lake Park Drive, 30080 Smyrna

Ticker Symbole

Name Symbol
NASDAQ GOVXW

Weitere Aktien

Investoren die GEOVAX LABS INC- WARRANTS die halten, haben auch folgende Aktien im Depot:
LBBW DL BOAP 15/22
LBBW DL BOAP 15/22 Anleihe
PFZ.SCHW.KTB 21/36
PFZ.SCHW.KTB 21/36 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025